Quorum sensing: a new prospect for the management of antimicrobial-resistant infectious diseases.
Mainul HaqueMd Salequl IslamMd Arif SheikhSameer DhingraPeace UwambayeFrancesco Maria LabricciosaKatia IskandarJaykaran CharanAlaeddin Bashir AbukabdaDilshad JahanPublished in: Expert review of anti-infective therapy (2020)
QSIs represent a novel opportunity to combat antimicrobial resistance (AMR). However, no clinical trials have been conducted thus far assessing their efficacy. With the recent advancements in technology and the development of well-designed clinical trials aimed at targeting various components of the, QS system, these agents will undoubtedly provide a useful alternative to treat infectious diseases.